Netflix beats expectations and reports stellar growth and forecasts for 2025. China could see 10% tariffs on goods going to the US from next month, which is lower than expected. UK public borrowing figures for Dec likely to weigh on bond market, and put pressure on UK to cut public spending quickly and rapidly.

Netflix surged late on earnings. President Trump touted a "Stargate" AI investment plan by Oracle, OpenAI and SoftBank.

Netflix is once again raising the price for its streaming service as the brand hits over 300 million subscribers across the globe.

Donald Trump’s threat of a 10% tariff on goods imported from China today led to weaker sessions for the Shanghai Composite and the Hang Seng index. The benchmarks have fallen 0.9% and 1.8% respectively, while the Nikkei 225 is up by 1.6% after last night’s positive Wall Street session.

President Donald Trump's boost to AI demand hopes is outweighing fresh tariff threats on China and the EU, as earnings season rolls on.

IMAX will partner with Netflix to release Greta Gerwig's 'Chronicles of Narnia' film adaptation on 1,000 screens for a month. Here's why.

Futures show both shares will keep on rising when markets open later on. Netflix is also on the up after reporting solid numbers, you can read the full Netflix report here, as part of our US company results coverage.

Global stock markets rallied this week amid Trump’s actions following his inauguration on Monday. European markets repeatedly hit new highs despite tariff threats, while the euro rebounded against the dollar.

FILE PHOTO: A trader works at the New York Stock Exchange (NYSE) next to a U.S. flag, after Republican Donald Trump won the U.S. presidential election, in New York City, U.S., November 6, 2024. REUTERS/Andrew Kelly/File Photo

Asian shares were mixed on Thursday after China rolled out more moves to try to boost its lagging stock markets by raising confidence that prices will rise. Officials in Beijing

Hong Kong shareholders of Shanghai Henlius Biotech on Wednesday rejected Chinese conglomerate Fosun International's buyout offer, which would have valued the drugmaker at HK$13.37 billion ($1.72 billion).

Follow along for live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.